Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha

被引:23
|
作者
Li, Guolin [1 ,2 ,3 ]
Brocker, Chad N. [1 ]
Yan, Tingting [1 ]
Xie, Cen [1 ]
Krausz, Kristopher W. [1 ]
Xiang, Rong [4 ,5 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Hunan Normal Univ, Coll Life Sci, Lab Aging Biochem, Changsha 410081, Hunan, Peoples R China
[3] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China
[4] Cent S Univ, State Key Lab Med Genet, Changsha 41001, Hunan, Peoples R China
[5] Cent S Univ, Sch Life Sci, Changsha 41001, Hunan, Peoples R China
来源
MOLECULAR METABOLISM | 2018年 / 7卷
基金
美国国家卫生研究院;
关键词
PPARA; PPARalpha; Intermittent fasting; Every-other-day fasting; Steatosis; Adaptive fasting response; FATTY-ACID OXIDATION; PPAR-ALPHA; HEPATIC STEATOSIS; LIVER-DISEASE; LIPID-METABOLISM; MICE; PHYSIOLOGY; MOUSE; MODEL; OBESITY;
D O I
10.1016/j.molmet.2017.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peroxisome proliferator-activated receptor alpha (PPARA) is a major regulator of fatty acid oxidation and severe hepatic steatosis occurs during acute fasting in Ppara-null mice. Thus, PPARA is considered an important mediator of the fasting response; however, its role in other fasting regiments such as every-other-day fasting (EODF) has not been investigated. Methods: Mice were pre-conditioned using either a diet containing the potent PPARA agonist Wy-14643 or an EODF regimen prior to acute fasting. Ppara-null mice were used to assess the contribution of PPARA activation during the metabolic response to EODF. Livers were collected for histological, biochemical, qRT-PCR, and Western blot analysis. Results: Acute fasting activated PPARA and led to steatosis, whereas EODF protected against fasting-induced hepatic steatosis without affecting PPARA signaling. In contrast, pretreatment with Wy-14,643 did activate PPARA signaling but did not ameliorate acute fasting-induced steatosis and unexpectedly promoted liver injury. Ppara ablation exacerbated acute fasting-induced hypoglycemia, hepatic steatosis, and liver injury in mice, whereas these detrimental effects were absent in response to EODF, which promoted PPARA-independent fatty acid metabolism and normalized serum lipids. Conclusions: These findings indicate that PPARA activation prior to acute fasting cannot ameliorate fasting-induced hepatic steatosis, whereas EODF induced metabolic adaptations to protect against fasting-induced steatosis without altering PPARA signaling. Therefore, PPARA activation does not mediate the metabolic adaptation to fasting, at least in preventing acute fasting-induced steatosis. Published by Elsevier GmbH.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 50 条
  • [21] Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha
    Orolin, J.
    Vecera, R.
    Jung, D.
    Meyer, U. A.
    Skottova, N.
    Anzenbacher, P.
    XENOBIOTICA, 2007, 37 (07) : 725 - 735
  • [22] Mechanistic insights into the peroxisome proliferator-activated receptor alpha as a transcriptional suppressor
    Yagai, Tomoki
    Nakamura, Takahisa
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
    Cluny, N. L.
    Keenan, C. M.
    Lutz, B.
    Piomelli, D.
    Sharkey, K. A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (04) : 420 - 429
  • [24] Signal crosstalk between estrogen and peroxisome proliferator-activated receptor α on adiposity
    Kim, Bang Hyun
    Won, Young Suk
    Kim, Dae Yong
    Kim, Bora
    Kim, Eun-Young
    Yoon, Mijung
    Oh, Goo Taeg
    BMB REPORTS, 2009, 42 (02) : 91 - 95
  • [25] Metabolic and nonmetabolic regulatory functions of peroxisome proliferator-activated receptor β
    Grimaldi, Paul A.
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (03) : 186 - 191
  • [26] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Wang, Lin
    Cai, Yin
    Jian, Liguo
    Cheung, Chi Wai
    Zhang, Liangqing
    Xia, Zhengyuan
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [27] Peroxisome proliferator-activated receptor beta/delta: a master regulator of metabolic pathways in skeletal muscle
    Lahiri, Shawon
    Wahli, Walter
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2010, 4 (02) : 565 - 573
  • [28] Peroxisome proliferator-activated receptor alpha-mediated drug toxicity in the liver
    Hedrington, Maka S.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (07) : 671 - 677
  • [29] Roles of peroxisome proliferator-activated receptor δ in skeletal muscle function and adaptation
    Fredenrich, A
    Grimaldi, PA
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (04) : 377 - 381
  • [30] Tributyltin is a potent inhibitor of piscine peroxisome proliferator-activated receptor α and β
    Colliar, Louise
    Sturm, Armin
    Leaver, Michael J.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2011, 153 (01): : 168 - 173